Guglielmo Parisi

Real-world comparative effectiveness of faricimab versus aflibercept 2 mg in treatment-naïve exudative neovascular AMD patients treated with a treat-and-extend regimen

Abstract Purpose To compare the real-world effectiveness of faricimab versus aflibercept 2 mg in treatment-naïve patients with neovascular age-related macular degeneration (nAMD). Methods We analysed treatment-naïve nAMD patients aged ≥50 years initiating intravitreal anti-VEGF t...